APA (7th ed.) Citation

Proost, L., Lambrecht, S., Hofmans, M., Vriendt, C. D., Speeckaert, M., Bonroy, C., . . . Bruyne, S. D. (2024). Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze. Wiley. https://doi.org/10.1002/hem3.39

Chicago Style (17th ed.) Citation

Proost, Lisa, Stijn Lambrecht, Mattias Hofmans, Ciel De Vriendt, Marijn Speeckaert, Carolien Bonroy, Barbara Denys, and Sander De Bruyne. Flow Cytometry Interference in Patients Treated with Tafasitamab: Unraveling the Diagnostic Maze. Wiley, 2024. https://doi.org/10.1002/hem3.39.

MLA (9th ed.) Citation

Proost, Lisa, et al. Flow Cytometry Interference in Patients Treated with Tafasitamab: Unraveling the Diagnostic Maze. Wiley, 2024. https://doi.org/10.1002/hem3.39.